Reposted by Benjamin Steinberg, MD, MHS
The STRIDE triad is HUGE for patients with PAD & DM. We need to learn more about WHY they were able to walk farther with semaglutide, but the benefits are very clear. All CVM clinicians need to be comfortable prescribing GLP1 agents. Kudos to Dr Bonaca and the study team!! #ACC25
